Event Videos
http://www.ncbi.nlm.nih.gov/ Marcellin P, Cooper C, Balart L, Larrey D, Box T, Yoshida E, Lawitz E,Buggisch P, Ferenci P, Weltman M, Labriola-Tompkins E, Le Pogam S, Nájera I,Thomas D, Hooper G, Shulman NS, Zhang Y, Navarro MT, Lim CY, Brunda M, Terrault NA, Yetzer ES. Randomized controlled trial of danoprevir plus peginterferonalfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype1 infection. Gastroenterology. Published on:
Oct-2013
|
http://www.ncbi.nlm.nih.gov/
Gulati R, Radhakrishnan KR, Hupertz V, Wyllie R, Alkhouri N, Worley S, Feldstein AE. Health-related quality of life in children with autoimmune liver disease. J Pediatr Gastroenterol Nutr. 2013 Oct; 57(4):444-50. Published on:
Oct-2013
|
http://www.ncbi.nlm.nih.gov/ Chen EY, Lee WM, Hynan LS, Singal AG. A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors. J Clin Gastroenterol.
Abstract
GOALS: Published on:
Oct-2013
|
http://www.ncbi.nlm.nih.gov/
Helbling D, Buchaklian A, Wang J, Wong LJ, Dimmock D. Reduced mitochondrial DNA content and heterozygous nuclear gene mutations in patients with acute liver failure. J Pediatr Gastroenterol Nutr. Published on:
Oct-2013
|
http://www.ncbi.nlm.nih.gov/
Lin CY, Sheen IS, Chen JY, Huang CW, Huang CH, Jeng WJ, Chen WT. Various predictors of sustained virologic response in different age groups of patientswith genotype-1 chronic hepatitis C. J Clin Gastroenterol. x Abstract
BACKGROUND: Published on:
Oct-2013
|
http://www.ncbi.nlm.nih.gov/
Giouleme O, Theocharidou E. Management of portal hypertension in children with portal vein thrombosis. J Pediatr Gastroenterol Nutr.
Abstract
Published on:
Oct-2013
|
http://www.ncbi.nlm.nih.gov/
Lawitz EJ, Rodriguez-Torres M, Denning J, Mathias A, Mo H, Gao B, Cornpropst MT, Berrey MM, Symonds WT. All-oral therapy with nucleotide inhibitors sofosbuvirand GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (nuclear). JViral Hepat. 2013 Oct; 20(10):699-707. Abstract
Published on:
Oct-2013
|
Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V. Serum cytokeratin-18 fragment levels are useful biomarkers for non-alcoholic steatohepatitis in children. Am J Gastroenterol.
Abstract
OBJECTIVES: Published on:
Sep-2013
|
http://www.ncbi.nlm.nih.gov/ Tapper EB, Afdhal NH. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3. J Viral Hepat.
Abstract
Published on:
Oct-2013
|
Sonneveld MJ, Hansen BE, Piratvisuth T, Jia JD, Zeuzem S, Gane E, Liaw YF, XieQ, Heathcote EJ, Chan HL, Janssen HL. Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels. Hepatology.
Published on:
Sep-2013
|